0
0
10/19/23 at 10:10pm
Organization
Targetedonc.com
33 words
0
Comments
Joshua Richter, MD, discusses the available combination therapies for patients with early relapsed/refractory multiple myeloma using anti-CD38 monoclonal antibodies.
You are the first to view
https://www.targetedonc.com/view/discussing-the-use-of-anti-cd38-combination-therapy-in-rrmm
Create an account
or login to join the discussion